---
title: "SONN.CVR.US (SONN.CVR.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SONN.CVR.US/news.md"
symbol: "SONN.CVR.US"
name: "SONN.CVR.US"
parent: "https://longbridge.com/en/quote/SONN.CVR.US.md"
datetime: "2026-05-20T19:09:49.274Z"
locales:
  - [en](https://longbridge.com/en/quote/SONN.CVR.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SONN.CVR.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SONN.CVR.US/news.md)
---

# SONN.CVR.US (SONN.CVR.US) — Related News

### [Creatv Announces Five Clinical Data Presentations at ASCO 2026](https://longbridge.com/en/news/285223983.md)
*2026-05-05T14:20:33.000Z*
> Creatv Bio, a cancer diagnostic blood testing company, announced one poster presentation and four poster abstracts for t

### [09:35 ETHengrui Pharma and Braveheart Bio Announce Positive Phase 2 Results with HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy](https://longbridge.com/en/news/281030940.md)
*2026-03-30T13:35:47.000Z*
> Hengrui Pharma and Braveheart Bio announced positive results from a Phase 2 study of HRS-1893 for obstructive hypertroph

### [Braveheart Bio appoints Marc Evanchik as CSO and Brittany de Temple as SVP, advancing towards global Phase 3 trials.](https://longbridge.com/en/news/274980565.md)
*2026-02-05T13:03:44.000Z*
> The company has promoted Marc Evanchik to the position of Chief Scientific Officer to oversee clinical development, rese